Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022

Published on December 8, 2022

This report describes a recent finding that mpox incidence among unvaccinated men aged 18-49 years was 10 times as high as vaccinated men who received both JYNNEOS doses.

Continue reading on website
Other news

SARS-CoV-2 Serology and Self-Reported Infection Among Adults - National Health and Nutrition Examination Survey, United States, August 2021-May 2022

December 1, 2022
This report describes COVID-19 serology and self-reported infections among adults.

Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged 18 Years Who Were Hospitalized or Died with Influenza - United States, 2021-22 Influenza Season

December 15, 2022
This report describes pediatric hospitalizations and deaths associated with coinfection of COVID-19 and influenza during the 2021-22 Influenza Season.